BOLT:NASDAQ, Bolt Biotherapeutics, Inc.

BOLT stock overview

Bolt Biotherapeutics, Inc. (BOLT:NASDAQ) closed at $6.08 on November 13, 2026, up 3.40% on the day. The stock trades 21.9% below its 52-week high of $7.78 and 96.1% above its 52-week low of $3.10. Over the past year, it gained 33.0%. Bolt Biotherapeutics, Inc. is part of the Health Care sector.

Key figures

Price: $6.08
Day change: +3.40%
Volume: 28,108
Average volume: 253,154
Market cap: 14M+
52-week range: $3.10 – $7.78
50-day average: $4.58
200-day average: $4.50

Price action over the past year

In 252 trading sessions since November 13, 2025, BOLT closed higher on 123 days (49%). Its best day was October 23, 2026 (+49.64%) and its worst was August 12, 2026 (-13.32%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

Nov 13, 2026: Trading sideways between $5.91 and $6.57 over 14 days (Sideways scanner)
Nov 12, 2026: News catalyst: Earnings (News Catalysts scanner)
Oct 23, 2026: Spiked to $7.78 on 12M+ shares (Spikes scanner)

BOLT news

Nov 12, 2026: Bolt Biotherapeutics, Inc.: Q3 Earnings Snapshot
Nov 12, 2026: Bolt Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 9, 2026: Coherus Oncology (CHRS) Reports Q3 Loss, Lags Revenue Estimates
Nov 6, 2026: Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Beats Revenue Estimates
Nov 4, 2026: Adaptive Biotechnologies (ADPT) Q3 Earnings and Revenues Top Estimates
Nov 3, 2026: Bolt Biotherapeutics to Participate in Upcoming Conferences
Oct 28, 2026: Lilly shuffles business structure; Novartis writes off part of Avidity deal
Oct 23, 2026: Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications

About Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

Similar stocks

Find more stocks like BOLT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.